Ozgural Onur, Kahilogullari Gokmen, Dogan Ihsan, Al-Beyati Eyyub S M, Bozkurt Melih, Tetik Bora, Comert Ayhan, Meco Cem, Unlu Agahan
Department of Neurosurgery, Faculty of Medicine, Ankara University, Ankara.
Department of Neurosurgery, Malatya Education and Research Hospital, Malatya.
J Craniofac Surg. 2018 Sep;29(6):e572-e578. doi: 10.1097/SCS.0000000000004592.
This study aimed to report the authors' single-center clinical experience about craniopharyngiomas and discuss surgical outcomes of these patients according to the type of surgical approach (endoscopic endonasal or open microscopic transcranial approach).Twenty-four patients diagnosed with craniopharyngiomas between May 2013 and April 2017 were considered for inclusion. The patients were divided into 2 groups according to the surgical approach (open transcranial microscopic approach [group A] and endoscopic endonasal approach [group B]). These groups were compared in terms of postoperative surgical outcome scores (extent of tumor removal, visual deficit, hydrocephalus, metabolic disorders, and Glasgow coma scale) and hospitalization interval.There was no patient of mortality in both groups. In this study, 4 of the 13 patients in group A and 9 of the 11 patients in group B underwent gross total resection. However, 1 patient in group B underwent repair because of cerebrospinal fluid leakage postoperatively. In addition, 1 patient in group A had a wound healing problem postoperatively. The postoperative outcome scores were 9.5 in group A and 11.5 in group B. The hospitalization interval in group A (range, 7-9 days) was longer than that in group B (range, 5-7 days).The endoscopic endonasal approach should be considered the first-line surgical treatment modality in patients with a preliminary diagnosis of craniopharyngioma in terms of low complication risk, minimal invasiveness, and better outcome scores. Open microscopic transcranial procedures may be combined with this approach in a single session for challenging cases.
本研究旨在报告作者关于颅咽管瘤的单中心临床经验,并根据手术入路类型(内镜经鼻或开放显微镜下经颅入路)讨论这些患者的手术结果。2013年5月至2017年4月期间诊断为颅咽管瘤的24例患者被纳入研究。根据手术入路将患者分为2组(开放经颅显微镜入路[A组]和内镜经鼻入路[B组])。比较两组的术后手术结果评分(肿瘤切除程度、视力缺损、脑积水、代谢紊乱和格拉斯哥昏迷量表)和住院时间。两组均无患者死亡。本研究中,A组13例患者中的4例和B组11例患者中的9例接受了全切除。然而,B组有1例患者因术后脑脊液漏进行了修补。此外,A组有1例患者术后出现伤口愈合问题。A组术后结果评分为9.5,B组为11.5。A组的住院时间(范围为7 - 9天)长于B组(范围为5 - 7天)。就低并发症风险、微创性和更好的结果评分而言,内镜经鼻入路应被视为初步诊断为颅咽管瘤患者的一线手术治疗方式。对于具有挑战性的病例,开放显微镜下经颅手术可与该入路在同一手术中联合使用。